×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
TNGX – tango therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
TNGX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/5
08:40 am
tngx
Tango Therapeutics, Inc. (NASDAQ: TNGX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Low
Report
Tango Therapeutics, Inc. (NASDAQ: TNGX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
12/3
07:00 am
tngx
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/27
07:00 am
tngx
Tango Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference
Medium
Report
Tango Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference
11/11
09:25 am
tngx
Tango Therapeutics, Inc. (NASDAQ: TNGX) had its price target lowered by analysts at B. Riley from $16.00 to $8.00. They now have a "buy" rating on the stock.
High
Report
Tango Therapeutics, Inc. (NASDAQ: TNGX) had its price target lowered by analysts at B. Riley from $16.00 to $8.00. They now have a "buy" rating on the stock.
11/8
02:32 pm
tngx
Tango Therapeutics, Inc. (NASDAQ: TNGX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock.
Medium
Report
Tango Therapeutics, Inc. (NASDAQ: TNGX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock.
11/7
02:34 pm
tngx
Tango Therapeutics, Inc. (NASDAQ: TNGX) had its price target lowered by analysts at Guggenheim from $18.00 to $8.00. They now have a "buy" rating on the stock.
Medium
Report
Tango Therapeutics, Inc. (NASDAQ: TNGX) had its price target lowered by analysts at Guggenheim from $18.00 to $8.00. They now have a "buy" rating on the stock.
11/6
10:15 am
tngx
Tango Therapeutics, Inc. (TNGX) Reports Q3 Loss, Tops Revenue Estimates [Yahoo! Finance]
Medium
Report
Tango Therapeutics, Inc. (TNGX) Reports Q3 Loss, Tops Revenue Estimates [Yahoo! Finance]
11/6
07:07 am
tngx
Tango Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights [Yahoo! Finance]
High
Report
Tango Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/6
11:15 am
tngx
Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: FMR LLC
Medium
Report
Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: FMR LLC
11/20
04:24 pm
tngx
Form SC 13G Tango Therapeutics, Inc. Filed by: TCG Crossover GP II, LLC
High
Report
Form SC 13G Tango Therapeutics, Inc. Filed by: TCG Crossover GP II, LLC
11/18
07:20 pm
tngx
Form 4 Tango Therapeutics, Inc. For: Nov 14 Filed by: Rothenberg Mace
Medium
Report
Form 4 Tango Therapeutics, Inc. For: Nov 14 Filed by: Rothenberg Mace
11/8
07:25 pm
tngx
Form 4 Tango Therapeutics, Inc. For: Nov 06 Filed by: EcoR1 Capital, LLC
High
Report
Form 4 Tango Therapeutics, Inc. For: Nov 06 Filed by: EcoR1 Capital, LLC
11/7
09:36 pm
tngx
Form SC 13D/A Tango Therapeutics, Inc. Filed by: Boxer Capital Management, LLC
Medium
Report
Form SC 13D/A Tango Therapeutics, Inc. Filed by: Boxer Capital Management, LLC
11/7
09:31 pm
tngx
Form 4 Tango Therapeutics, Inc. For: Nov 06 Filed by: Davis Aaron I.
Medium
Report
Form 4 Tango Therapeutics, Inc. For: Nov 06 Filed by: Davis Aaron I.
11/6
09:41 pm
tngx
Form 144 Tango Therapeutics, Inc. Filed by: Boxer Capital Management, LLC
High
Report
Form 144 Tango Therapeutics, Inc. Filed by: Boxer Capital Management, LLC
11/6
07:43 am
tngx
Form 10-Q Tango Therapeutics, Inc. For: Sep 30
High
Report
Form 10-Q Tango Therapeutics, Inc. For: Sep 30
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: